HCA Healthcare, Inc. $HCA Shares Sold by Arlington Trust Co LLC

Arlington Trust Co LLC cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 67.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 750 shares of the company’s stock after selling 1,536 shares during the period. Arlington Trust Co LLC’s holdings in HCA Healthcare were worth $350,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the company. Capital World Investors lifted its stake in HCA Healthcare by 3.8% during the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after purchasing an additional 179,443 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in HCA Healthcare by 1.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after purchasing an additional 36,414 shares in the last quarter. Viking Global Investors LP lifted its stake in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Legal & General Group Plc lifted its stake in HCA Healthcare by 0.8% during the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock worth $479,267,000 after purchasing an additional 8,478 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in HCA Healthcare by 1.1% during the third quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock worth $469,216,000 after purchasing an additional 11,829 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. Leerink Partners cut their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday. KeyCorp cut their price objective on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday. Wall Street Zen lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $523.09.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Management reaffirmed FY2026 guidance and expects 2%–3% volume growth while acknowledging headwinds, which supports the company’s forward earnings outlook. HCA projects 2%-3% volume growth
• Positive Sentiment: HCA says improvements in its revenue‑cycle operations are boosting cash collections and helping offset rising denials/underpayments — a near‑term margin and cash‑flow positive. Revenue cycle paying dividends
• Positive Sentiment: Leadership hire: Cynthia Cifuentes‑Finkel will become SVP of Marketing & Corporate Affairs (effective June 8), adding senior marketing/communications capacity ahead of growth initiatives. HCA names new SVP
• Neutral Sentiment: Local operations: a new HCA Florida Gainesville hospital is preparing to open next month — incremental local growth but limited immediate impact on enterprise results. Gainesville hospital opening
• Neutral Sentiment: Market commentary pieces and index signals are discussing healthcare positioning; useful for macro context but not company‑specific catalysts. Market update
• Negative Sentiment: Multiple analysts reduced price targets and trimmed forecasts after Q1 results (despite an in‑line EPS), signaling more cautious near‑term sentiment. Firms lowering targets include Stephens, Oppenheimer, TD Cowen, Leerink, RBC and Truist. Analysts slash forecasts
• Negative Sentiment: Q1 dynamics: EPS roughly in‑line but seasonal volume softness, shifting payer mix and projected ACA/exchange pressures (company cites a $600M–$900M headwind range) are weighing on near‑term revenue and margin expectations. Q1 deep dive
• Negative Sentiment: Financing: HCA filed a proposed public offering of senior notes to raise proceeds for general corporate purposes (may include refinancing). New debt issuance could modestly pressure credit metrics depending on size and terms. Proposed senior notes offering

HCA Healthcare Price Performance

NYSE:HCA opened at $446.38 on Tuesday. The firm has a market capitalization of $99.80 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36. The business’s fifty day moving average price is $503.58 and its 200 day moving average price is $486.01. HCA Healthcare, Inc. has a 12 month low of $326.14 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.